JPRN-jRCT1030230162招募中Unknown
Mutation testing,treatment patterns, and outcomes in EGFR mutated unresectable nonsmall cell lung cancer patients. A Retrospective Observational Study - LEROS
ICCC: 3H Medi Solution Inc.0 个研究点目标入组 120 人开始时间: 2023年6月24日最近更新:
适应症
试验速览
- 阶段
- Unknown
- 状态
- 招募中
- 发起方
- 入组人数
- 120
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- >= 20age old 至 ot applicable（—）
- 性别
- All
入选标准
- •Histologically and lab-confirmed diagnosis of stage III NSCLC
- •-Histologically and lab-confirmed diagnosis of stage I-II NSCLC
- •-Tumor harbors at least 1 of the 2 common EGFRms: Exon 19 deletion or L858R
排除标准
- •-Evidence of other cancer diagnoses (apart from basal cell carcinoma) within one year prior to the index diagnosis date
- •-Participated in an investigational clinical trial for the treatment of any cancer, including NSCLC, or any early access program from 2016 onward
研究者
相似试验
已完成
不适用
A feasibility study of performance of a novel method for gene mutations in circulating tumor DNAnon-small cell lung cancerJPRN-UMIN000038679West Japan Oncology Group10
招募中
不适用
Observational study on gene mutation and prognosis for patients with resectable pancreatic cancerpancreatic cancerJPRN-UMIN000032917Kobe university219
进行中（未招募）
不适用
Mutation Screening and Clinical Findings in a Family with Oguchi Disease in TurkeyOguchi night blindnessEye - Diseases / disorders of the eyeACTRN12615001113549Ankara Ulucanlar Eye Education and Research Hospital6
已完成
不适用
Clinical assessment of patients with a mutation in the IGSF1 geneNL-OMON41375eids Universitair Medisch Centrum30
进行中（未招募）
不适用
A study to assess the incidence in the UK of a change in a protein found in patients with newly diagnosed non-small cell lung cancer which has advanced or spread, and to investigate the quality of life of these patients when they receive treatment with erlotinib (Tarceva®) alone as a first treatment for this stage of their disease.EUCTR2010-021120-96-GBRoche Products Limited1,200